The world of nano-tech research has been, of late, giving birth to many promising cancer fighting technologies. These have come in many different forms, including cancer detection, cell monitoring, and tumor eradication, however they all share one commonality: most cancer nanotechnologies being developed today are based on a single-function design. This may be due to surface area constrictions that must be considered by researchers designing nano-scale structures, since most specific functions are carried out by nanoparticles located on the spatially limited surface of the primary nano-device.
University of Cincinnati scientists partnered with researchers from Tongji University (Shanghai), Stanford University, and University of Houston, and will be presenting at the upcoming Materials Science & Technology Conference in Montreal, Canada this week their research in the field of multi-functional cancer-fighting nanotechnology. Specifically, they have developed a nano-carrier that may be capable of transporting a variety of cancer-fighting nanoparticles on its double sided surface. The nano-carrier should be able to deliver fluorescent biomarkers and cancer-detecting nanoparticles to the target site within the body, attach fluorescent markers cancer cells (for identification and targeting purposes), transport anti-cancer drugs to the tumor, and use smart technology to deliver precise doses of medication only where necessary.
From the announcement:
““In this effort, we’re using existing basic nano systems, such as carbon nanotubes, graphene, iron oxides, silica, quantum dots and polymeric nano materials in order to create an all-in-one, multidimensional and stable nano carrier that will provide imaging, cell targeting, drug storage and intelligent, controlled drug release,” said UC’s Shi, adding that the nano carrier’s promise is currently greatest for cancers that are close to the body’s surface, such as breast and prostate cancer.”
More information: UC Develops Unique Nano Carrier to Target Drug Delivery to Cancer Cell…